James R. Sulat

Chief Executive Officer, MEMORY PHARMACEUTICALS CORP.

Companies

Keenova Therapeutics plcBoard member Jun 24, 2022 to Nov 16, 2023¹
EXICURE, INC.Board member Jan 5, 2021 to Jun 15, 2022²
Arch Therapeutics, Inc.Board member Aug 20, 2015 to Oct 1, 2021³
AMAG PharmaceuticalsBoard member Apr 16, 2014 to Nov 17, 2020⁴
MaxygenChief executive officer Jan 17, 2013 to Jul 1, 2013⁵
MaxygenChief financial officer Jan 17, 2013 to Jul 1, 2013⁵
MaxygenBoard member May 31, 2006 to Jul 1, 2013⁶
CodexisBoard member Apr 21, 2010 to Apr 29, 2010⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Keenova Therapeutics plc0 shares⁸Nov 14, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 14, 2023Returned to company 53,122 shares of Keenova Therapeutics plc⁸
Jun 16, 2023Returned to company 26,277 shares of Keenova Therapeutics plc⁹
Jun 16, 2023Shares withheld for tax 3,154 shares at $1.28 of Keenova Therapeutics plc⁹
Mar 15, 2023Bought 15,000 shares at $8.54 of Keenova Therapeutics plc¹⁰
Mar 14, 2023Bought 15,000 shares at $8.42 of Keenova Therapeutics plc¹⁰
Jan 3, 2023Granted 26,277 shares of Keenova Therapeutics plc¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKeenova Therapeutics plc, Board member
2
SEC EDGAREXICURE, INC., Board member
3
SEC EDGARArch Therapeutics, Inc., Board member
4
SEC EDGARAMAG Pharmaceuticals, Board member
5
SEC EDGARMaxygen, Chief executive officer
6
SEC EDGARMaxygen, Board member
7
SEC EDGARCodexis, Board member
8
SEC EDGARKeenova Therapeutics plc shares after the filing of Nov 14, 2023
9
SEC EDGARForm 4 filed Jun 29, 2023
10
SEC EDGARForm 4 filed Mar 16, 2023
11
SEC EDGARForm 4 filed Jan 5, 2023